We are live on ! Find out more
Steven Cohen

Steven Cohen Point72 Asset Management

AUM $90B Turnover 35.95%
1-Year Est. Return 47.32%
 

Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.

This Fund
S&P 500
This Quarter Est. Return
-0.87%
1 Year Est. Return
+47.32%
3 Year Est. Return
+196.68%
5 Year Est. Return
+253.31%
10 Year Est. Return
+901.75%
AUM
$90B
AUM Growth
-$633M
Cap. Flow
-$1.03B
Cap. Flow %
-1.15%
Top 10 Hldgs %
9.57%
Holding
4,740
New
820
Increased
1,398
Reduced
1,421
Closed
884
Avg Time Held Equity + Options
0.8 years
Top 10 Avg Time Held Equity + Options
1.5 years
Top 20 Avg Time Held Equity + Options
1 year
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$936M
2
CLS icon
Celestica
CLS
+$624M
3
INTC icon
Intel
INTC
+$414M
4
BA icon
Boeing
BA
+$390M
5
T icon
AT&T
T
+$357M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$677M
2
ASML icon
ASML
ASML
+$524M
3
ORCL icon
Oracle
ORCL
+$445M
4
TSM icon
TSMC
TSM
+$444M
5
SNOW icon
Snowflake
SNOW
+$365M

Sector Composition

Rank Sector Weight
1 Miscellaneous 33.57%
2 Technology 18.01%
3 Industrials 8.74%
4 Consumer Discretionary 8.72%
5 Healthcare 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TGTX icon
3201
PUT
TG Therapeutics
TGTX
$9.6B
$357K ﹤0.01%
6,400
– –
2026 Q2
1 quarter
TOST icon
3202
CALL
Toast
TOST
$18.3B
$357K ﹤0.01%
+12,300
New +$396K
2026 Q3
0 quarters
FENC icon
3203
Fennec Pharmaceuticals
FENC
$462M
$356K ﹤0.01%
33,414
-22,993
-41% -$253K
2026 Q2
1 quarter
BMBL icon
3204
Bumble
BMBL
$925M
$356K ﹤0.01%
+135,307
New +$389K
2026 Q3
0 quarters
RPC icon
3205
Ridgepost Capital
RPC
$987M
$355K ﹤0.01%
+47,839
New +$398K
2026 Q3
0 quarters
HRB icon
3206
CALL
H&R Block
HRB
$5.59B
$355K ﹤0.01%
8,700
-21,000
-71% -$956K
2026 Q1
2 quarters
ACI icon
3207
CALL
Albertsons Companies
ACI
$5.69B
$355K ﹤0.01%
+30,600
New +$387K
2026 Q3
0 quarters
HNVR icon
3208
Hanover Bancorp
HNVR
$149M
$352K ﹤0.01%
+14,136
New +$369K
2026 Q3
0 quarters
PODD icon
3209
CALL
Insulet
PODD
$9.24B
$352K ﹤0.01%
2,700
-3,600
-57% -$539K
2025 Q4
3 quarters
ADMA icon
3210
PUT
ADMA Biologics
ADMA
$2.92B
$352K ﹤0.01%
35,100
– –
2026 Q2
1 quarter
SGMT icon
3211
Sagimet Biosciences
SGMT
$648M
$352K ﹤0.01%
+35,629
New +$327K
2026 Q3
0 quarters
KSS icon
3212
PUT
Kohl's
KSS
$2.52B
$351K ﹤0.01%
+19,000
New +$343K
2026 Q3
0 quarters
RELY icon
3213
CALL
Remitly
RELY
$4.24B
$350K ﹤0.01%
16,400
+200
+1% +$4.78K
2026 Q2
1 quarter
KBWB icon
3214
PUT
Invesco KBW Bank ETF
KBWB
$6.13B
$349K ﹤0.01%
4,000
-27,600
-87% -$2.64M
2025 Q4
3 quarters
NAVN icon
3215
PUT
Navan
NAVN
$6.3B
$348K ﹤0.01%
16,600
+6,400
+63% +$165K
2026 Q2
1 quarter
VEA icon
3216
Vanguard FTSE Developed Markets ETF
VEA
$210B
$348K ﹤0.01%
+4,931
New +$354K
2026 Q3
0 quarters
BNED icon
3217
Barnes & Noble Education
BNED
$422M
$347K ﹤0.01%
29,948
-6,749
-18% -$80.9K
2026 Q2
1 quarter
APC icon
3218
ARKO Petroleum
APC
$625M
$346K ﹤0.01%
23,260
-2,664
-10% -$50.5K
2026 Q2
1 quarter
UTI icon
3219
CALL
Universal Technical Institute
UTI
$946M
$345K ﹤0.01%
18,500
+14,100
+320% +$427K
2026 Q2
1 quarter
EWG icon
3220
iShares MSCI Germany ETF
EWG
$1.87B
$345K ﹤0.01%
+8,352
New +$357K
2026 Q3
0 quarters
JYNT icon
3221
The Joint Corp
JYNT
$84.7M
$345K ﹤0.01%
46,587
-29,932
-39% -$254K
2026 Q2
1 quarter
RNAC icon
3222
Cartesian Therapeutics
RNAC
$187M
$345K ﹤0.01%
47,783
+4,156
+10% +$36.2K
2026 Q2
1 quarter
HCKT icon
3223
Hackett Group
HCKT
$312M
$342K ﹤0.01%
+34,071
New +$364K
2026 Q3
0 quarters
KLAR icon
3224
PUT
Klarna Group
KLAR
$4.57B
$342K ﹤0.01%
27,600
-29,000
-51% -$484K
2026 Q2
1 quarter
BILI icon
3225
CALL
Bilibili
BILI
$4.24B
$341K ﹤0.01%
22,700
-1,400
-6% -$23.7K
2026 Q2
1 quarter

Similar funds

Steven Cohen's Q3 2026 Portfolio in Review

As of Q3 2026, Steven Cohen held 4,740 positions worth $90B, down 0.7% from $90.7B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Steven Cohen's Q3 2026 filing shows 820 new, 1,398 increased, 1,421 reduced and 884 closed positions. Its largest new stake was Celestica: 1,886,416 shares worth $682M. The largest sale was Advanced Micro Devices, an estimated $677M.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.

  • Steven Cohen's largest Q3 2026 buy was Celestica: 1,886,416 shares worth $682M.
  • Steven Cohen added most to Microsoft in Q3 2026, an estimated $936M increase.
  • Steven Cohen's biggest Q3 2026 reduction was Advanced Micro Devices, cutting an estimated $677M.
  • Steven Cohen fully exited Visa in Q3 2026, selling an estimated $297M.
  • Steven Cohen's ten largest holdings make up 9.6% of its $90B portfolio in Q3 2026.
  • Steven Cohen opened 820 new positions and closed 884 in Q3 2026.
  • Steven Cohen's portfolio value fell 0.7% quarter-over-quarter to $90B.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.